CN103156915A - Medicine composition used for treating hepatitis C - Google Patents
Medicine composition used for treating hepatitis C Download PDFInfo
- Publication number
- CN103156915A CN103156915A CN2011104118511A CN201110411851A CN103156915A CN 103156915 A CN103156915 A CN 103156915A CN 2011104118511 A CN2011104118511 A CN 2011104118511A CN 201110411851 A CN201110411851 A CN 201110411851A CN 103156915 A CN103156915 A CN 103156915A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine composition
- medicine
- hepatitis
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of medicine, and specifically relates to a medicine composition used for treating hepatitis C. The medicine composition is prepared from the raw materials of Chinese herbal medicines. The medicine composition is prepared from the raw materials of, by weight, 1-5 parts of Chinese thorowax root, 3-5 parts of salvia miltiorrhiza, 2-4 parts of panax pseudo-ginseng, and 3-5 parts of capillary wormwood herb. The medicine provided by the invention has the functions such as Shaoyang reconciliating, liver soothing, qi regulating, stomach regulating, and the like. The medicine composition is used for treating typhoid Shaoyang disease. The disease causes symptoms such as cold and heat exchanges, chest rib bitter fullness, no appetite, vomiting, bitter mouth, dry throat, dizziness, blood chamber heat, chest irritability, thin white tongue coating, and pulse string.
Description
Technical field
The present invention relates in medical technical field, be specifically related to a kind of pharmaceutical composition of the treatment hepatitis C of making take Chinese herbal medicine as raw material.
Background technology
The clinical experience for the treatment of by Chinese herbs hepatitis C is quite ripe, and its typing and hepatitis B are roughly the same, can be divided into not clear person's six types of damp and hot middle resistance, stagnation of liver-QI with deficiency of the spleen, the hepatic and renal YIN deficiency, obstruction of collaterals by blood stasis, deficiency of spleen-YANG and kidneyYANG and pattern of syndrome.Because hepatitis C is many through Transfusion Transmission, be easy to chronicity, its pathogenic characteristic of thinking that therefore has is that malicious heresy directly enters nutrient blood, evil easily poly-, the person who suffer from deficiency of kidney Yang susceptible of poison, advocates accordingly to control take promoting blood circulation and detoxication, soothing the liverly reduces phlegm, liver and kidney tonifying, elevate a turnable ladder yang-energy be as main.Also have advocate take liver heat removing, removing heat from blood, let out that poison, righting holder are evil, blood stasis dispelling and network be as main method for the treatment of person.But existing medicine is made complicated, and effect is obvious not.
Summary of the invention
In view of this, the invention provides a kind of pharmaceutical composition that can effectively treat hepatitis C.
The objective of the invention is to be achieved through the following technical solutions: the pharmaceutical composition for the treatment of hepatitis C comprises that the crude drug of following weight proportion is formulated: Radix Bupleuri 1-5 part, Radix Salviae Miltiorrhizae 3-5 part, Typhonium flagelliforme (Lodd.) Blume 2-4 part, Herba Artemisiae Scopariae 3-5 part.
Further, 4 parts of Radix Bupleuri, 4 parts of Radix Salviae Miltiorrhizaes, 4 parts of Typhonium flagelliforme (Lodd.) Blume, 4 parts of Herba Artemisiae Scopariaes.
Further, also comprise acceptable adjuvant in pharmacy.
The invention has the beneficial effects as follows: this medicine has treating SHAO YANG disease by mediation, the effects such as liver-smoothing, qi-regulating stomach function regulating.Be used for the few positive disease of typhoid fever.Card is seen alternate attack of chill and fever, and costa sternales is bitter full, loss of appetite, and happiness is vomitted, bitter taste, dry pharynx, dizzy, invasion of the blood-chamber by heat, and is irritated in the heart, thin white fur of tongue, stringy pulse person.Hepatitis C patients adopts medicine composite for curing of the present invention, can feel all that after taking medicine symptom alleviates to some extent, and remission time is fast, especially the patient with severe symptoms has shortened in hospital and administration time greatly, alleviated patient's financial burden, reduced the generation of drug side effect, patients ' life quality is greatly improved.
Other advantages of the present invention, target and feature will be set forth in the following description, and to a certain extent, based on being apparent to those skilled in the art to investigating hereinafter, perhaps can be instructed from the practice of the present invention.Target of the present invention and other advantages can realize and obtain by following description and claims.
The specific embodiment
Below will be described in detail the preferred embodiments of the present invention.Should be appreciated that preferred embodiment only for the present invention is described, rather than in order to limit protection scope of the present invention.
The pharmaceutical composition for the treatment of hepatitis C comprises that in the crude drug of following weight proportion and pharmacy, acceptable adjuvant is formulated: Radix Bupleuri 1-5 part, Radix Salviae Miltiorrhizae 3-5 part, Typhonium flagelliforme (Lodd.) Blume 2-4 part, Herba Artemisiae Scopariae 3-5 part.
Embodiment 1
4 parts of Radix Bupleuri, 4 parts of Radix Salviae Miltiorrhizaes, 4 parts of Typhonium flagelliforme (Lodd.) Blume, 4 parts of Herba Artemisiae Scopariaes.
Embodiment 2
1 part of Radix Bupleuri, 3 parts of Radix Salviae Miltiorrhizaes, 3 parts of Typhonium flagelliforme (Lodd.) Blume, 5 parts of Herba Artemisiae Scopariaes.
Embodiment 3
5 parts of Radix Bupleuri, 5 parts of Radix Salviae Miltiorrhizaes, 2 parts of Typhonium flagelliforme (Lodd.) Blume, 3 parts of Herba Artemisiae Scopariaes.
Explanation is at last, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although with reference to preferred embodiment, the present invention is had been described in detail, those of ordinary skill in the art is to be understood that, can modify or be equal to replacement technical scheme of the present invention, and not breaking away from aim and the scope of the technical program, it all should be encompassed in the middle of claim scope of the present invention.
Claims (3)
1. pharmaceutical composition for the treatment of hepatitis C, it is characterized in that: the crude drug that comprises following weight proportion is formulated: Radix Bupleuri 1-5 part, Radix Salviae Miltiorrhizae 3-5 part, Typhonium flagelliforme (Lodd.) Blume 2-4 part, Herba Artemisiae Scopariae 3-5 part.
2. the pharmaceutical composition for the treatment of hepatitis C according to claim 1, is characterized in that: 4 parts of Radix Bupleuri, 4 parts of Radix Salviae Miltiorrhizaes, 4 parts of Typhonium flagelliforme (Lodd.) Blume, 4 parts of Herba Artemisiae Scopariaes.
3. the pharmaceutical composition for the treatment of hepatitis C according to claim 1 and 2, is characterized in that: also comprise acceptable adjuvant in pharmacy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104118511A CN103156915A (en) | 2011-12-13 | 2011-12-13 | Medicine composition used for treating hepatitis C |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104118511A CN103156915A (en) | 2011-12-13 | 2011-12-13 | Medicine composition used for treating hepatitis C |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103156915A true CN103156915A (en) | 2013-06-19 |
Family
ID=48580780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104118511A Pending CN103156915A (en) | 2011-12-13 | 2011-12-13 | Medicine composition used for treating hepatitis C |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103156915A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250361A (en) * | 2015-11-27 | 2016-01-20 | 史克勇 | Traditional Chinese medicine composition capable of protecting liver |
| CN105267272A (en) * | 2015-11-27 | 2016-01-27 | 史克勇 | Traditional Chinese medicine used for protecting livers |
| CN107753818A (en) * | 2017-11-28 | 2018-03-06 | 李习军 | A kind of Chinese medicine for treating hepatopathy |
-
2011
- 2011-12-13 CN CN2011104118511A patent/CN103156915A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250361A (en) * | 2015-11-27 | 2016-01-20 | 史克勇 | Traditional Chinese medicine composition capable of protecting liver |
| CN105267272A (en) * | 2015-11-27 | 2016-01-27 | 史克勇 | Traditional Chinese medicine used for protecting livers |
| CN107753818A (en) * | 2017-11-28 | 2018-03-06 | 李习军 | A kind of Chinese medicine for treating hepatopathy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463609A (en) | Traditional Chinese medicine oral decoction for treating upper respiratory infection and preparation method for Chinese patent medicine of traditional Chinese medicine oral decoction | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN105412749A (en) | Medicine for treating infantile pneumonia with dyspnea and cough and preparation method and application method thereof | |
| CN101057942B (en) | External applied medicine ointment for treating diabetes foot and its preparing method | |
| CN101129636A (en) | Medicine for treating nasal inflammation | |
| CN103156915A (en) | Medicine composition used for treating hepatitis C | |
| CN103239579B (en) | Chinese medicine composition for treating acute facioplegia and preparation method thereof | |
| CN102526459B (en) | Traditional Chinese medicine composition for treating nasosinusitis and preparation method thereof | |
| CN101129569A (en) | Orally taken traditional Chinese medicine medicinal decoction for treating acute sinusitis | |
| CN102641425B (en) | Chinese herbal preparation for curing child acute pneumonia | |
| CN103142872B (en) | Chinese medicine composition for treating wind-heat common cold | |
| CN104800570A (en) | Chinese herbal preparation for treating pneumonia | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN1175880C (en) | Medicine for curing nasal sinusitis | |
| CN1931262A (en) | Common cold treating Chinese medicine prepn | |
| CN104107352A (en) | Chinese herbal medicine for blood pressure reducing, and administration method thereof | |
| CN103948748A (en) | Traditional Chinese medicament for treating diabetes mellitus | |
| CN104173737A (en) | Traditional Chinese medicine formula for treating pulmonary interstitial fibrosis | |
| CN103417920A (en) | Traditional Chinese medicine formula for treating interstitial pneumonia | |
| CN106389768A (en) | Medicine composition for treating nasal diseases and preparation method thereof | |
| CN105148206A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN103463293B (en) | Method for preparing traditional Chinese medicine composite for treating lumbar spinal stenosis | |
| CN102973823B (en) | Chinese traditional medicine for cold-pungent diaphoresis | |
| CN105641464A (en) | Traditional Chinese medicinal composition for treating pulpitis | |
| CN102641374B (en) | Traditional Chinese decoction for treating chronic bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130619 |